Sree Rayalaseema Hi-Strength Hypo Intrinsic Value
Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) median intrinsic value is ₹389.92 from 9 valuation models (range ₹303–₹780), vs current price ₹523.10 — -25.5% downside (Trading Above Calculated Value), margin of safety -34.2%. Check SRHHYPOLTD market capitalization to track the company's total market size over time.
SRHHYPOLTD Valuation Methods Summary — DCF, Graham Number & P/E
Sree Rayalaseema Hi-Strength Hypo intrinsic value across 9 models vs current price ₹523.10 — upside/downside and value range per method. For current market price and key ratios, visit Sree Rayalaseema Hi-Strength H screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹567.84 | ₹454.27 - ₹681.41 | +8.6% | EPS: ₹47.32, Sector P/E: 12x |
| Book Value Method | asset | ₹571.18 | ₹514.06 - ₹628.30 | +9.2% | Book Value/Share: ₹571.18, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹340.71 | ₹306.64 - ₹374.78 | -34.9% | Revenue/Share: ₹425.88, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹367.06 | ₹330.35 - ₹403.77 | -29.8% | EBITDA: ₹104.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹360.43 | ₹288.34 - ₹432.52 | -31.1% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹302.85 | ₹272.57 - ₹333.14 | -42.1% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹389.92 | ₹350.93 - ₹428.91 | -25.5% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹470.59 | ₹423.53 - ₹517.65 | -10.0% | ROE: 8.2%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹779.83 | ₹701.85 - ₹857.81 | +49.1% | EPS: ₹47.32, BVPS: ₹571.18 |
SRHHYPOLTD Intrinsic Value vs Market Price — All Valuation Models
Sree Rayalaseema Hi-Strength Hypo fair value range ₹303–₹780 vs current market price ₹523.10 across 9 valuation models. See SRHHYPOLTD price to book ratio to compare market price against book value per share.
SRHHYPOLTD Intrinsic Value Analysis — Undervalued or Overvalued?
Sree Rayalaseema Hi-Strength Hypo median intrinsic value ₹389.92, current price ₹523.10 — Trading Above Calculated Value by 25.5%, margin of safety -34.2%.
What is the intrinsic value of SRHHYPOLTD?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) is ₹389.92 (median value). With the current market price of ₹523.10, this represents a -25.5% variance from our estimated fair value.
The valuation range spans from ₹302.85 to ₹779.83, indicating ₹302.85 - ₹779.83.
Is SRHHYPOLTD undervalued or overvalued?
Based on our multi-method analysis, Sree Rayalaseema Hi-Strength Hypo (SRHHYPOLTD) appears to be trading above calculated value by approximately 25.5%.
SRHHYPOLTD Financial Health — Key Ratios vs Industry Benchmarks
Sree Rayalaseema Hi-Strength Hypo financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.72 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 8.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.65x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SRHHYPOLTD Cash Flow Quality — Operating & Free Cash Flow
Sree Rayalaseema Hi-Strength Hypo operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹66 Cr | ₹62 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹140 Cr | ₹130 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹141 Cr | ₹85 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹60 Cr | ₹60 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹71 Cr | ₹14 Cr | Positive Free Cash Flow | 7/10 |